Hadijat Motunrayo Adegoke

Hadijat Motunrayo Adegoke

Auto-generated profile, based on publicly available information

Hadijat Motunrayo Adegoke

1) Computational and Biophysical Chemistry Unit, Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, LAUTECH, Ogbomoso, Oyo State 2) Genomics Unit, Helix Biogen Institute, Ogbomoso, Oyo State

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Majalah Obat Tradisional
Verified
Journal Article
Open access
PDF file
MAMisbaudeen Abdul-Hammed
Misbaudeen Abdul-Hammed
IOIbrahim Adedotun Olaide
Ibrahim Adedotun Olaide
HAHadijat Motunrayo Adegoke
Hadijat Motunrayo Adegoke
MOMonsurat Olajide
Monsurat Olajide
OOOluwasegun Johnson Osilade
Oluwasegun Johnson Osilade
AAAdelayo Idayat Abdul-Hammed
Adelayo Idayat Abdul-Hammed
Fungal infection has become a persistent problem in humans and is sometimes life-threatening in immune-compromised individuals. This work aims to study phytochemicals from Annona muricata (sour sop) as probable antifungal agents against Candida albicans sterol 14α-demethylase target receptor by Computer Aided-Drug Design (CADD) approach using voriconazole and fluconazole as standard drugs. A modern method of drug discovery by molecular docking and chemoinformatics was used to screen 131 isolated phytochemicals with medicinal properties from Annona muricata against Candida albicans ‘sterol 14α-demethylase, a prominent target receptor for most anti-fungal drugs, towards the development of new anti-fungal therapeutic agents and a new approach to treat patients with fungal infections. The compounds were all subjected to analyses like ADMET, drug-likeness, bioactivity, oral-bioavailability and PASS. The results of the docking simulation and chemoinformatics analyses showed that muricin M (-7.9 kcal/mol), chlorogenic acid (-8.2 kcal/mol), roseoside (-8.5 kcal/mol) and caffeoylquinic acid (-8.1 kcal/mol) are potential drug candidates for treating fungal infections due to their excellent properties such as binding affinities, ADMET profile, drug-likeness, bioactivity, binding mode and interactions with the target receptor. Thus, muricin M, chlorogenic acid, roseoside and caffeoylquinic acid are recommended for further analyses towards the development of further antifungal drugs.